Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option
WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB:CMRA) ("Comera" or the "Company"), a life sciences company developing a proprietary drug-delivery technology to improve
Comera Life Sciences Announces Process Exploring Strategic Alternatives
WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB:CMRA) ("Comera" or the "Company"), a life sciences company developing a new generation of biologic medicines to improve
Comera Life Sciences(CMRA.US) Officer Buys US$708 in Common Stocks
$Comera Life Sciences(CMRA.US)$ Officer Campbell Michael Gerard purchased 10,000 shares of Common Stocks on Nov 27, 2023 at an average price of $0.0708 for a total value of $708.Source: Announcement W
Comera Life Sciences Designates Dorothy Clarke to Board of Directors
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) today announced it appointed Dorothy Clarke to its board of directors.
Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.10) per share. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported
Comera Life Sciences 3Q Rev $136,310 >CMRA
Comera Life Sciences 3Q Rev $136,310 >CMRA
Comera Life Sciences Presents SQore Platform Technology Data at PODD: Partnerships in Drug Delivery Conference
Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) today will present research demonstrating Comera's SQore platform capabilities in the development of subcutaneous monoclonal antibody formulations at the PODD: Partnerships in Drug Delivery conference in Boston, Mass.
12 Health Care Stocks Moving In Friday's Intraday Session
GainersBio-Path Hldgs (NASDAQ:BPTH) shares rose 60.6% to $0.63 during Friday's regular session. Bio-Path Hldgs's stock is trading at a volume of 111.1 million shares as of 13:30 EST. This is 15820.7%
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock increased by 158.8% to $1.02 during Thursday's after-market session. Today's trading volume for this security ended up closing at 18.9 million shares, which i
12 Health Care Stocks Moving In Friday's After-Market Session
GainersBionomics (NASDAQ:BNOX) stock moved upwards by 24.0% to $3.46 during Friday's after-market session. Today's trading volume for this security ended up closing at 1.8 million shares, which is 85.
Stocks That Hit 52-Week Lows On Thursday
During the session on Thursday, 461 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Pfizer (NYSE:PFE
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersAxcella Health (NASDAQ:AXLA) stock rose 76.6% to $1.26 during Tuesday's regular session. As of 13:30 EST, Axcella Health's stock is trading at a volume of 67.4 million, which is 427.8% of its a
Comera Life Sciences Files Prospectus For The Offer And Resale Of 27,863,058 Shares Of Common Stock By Selling Stockholders
Comera Life Sciences Files Prospectus For The Offer And Resale Of 27,863,058 Shares Of Common Stock By Selling Stockholders
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAxcella Health (NASDAQ:AXLA) shares increased by 222.2% to $0.36 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Tivic Health Systems (NASDAQ:TIVC) stock
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersBionomics (NASDAQ:BNOX) stock increased by 15.0% to $1.76 during Monday's pre-market session. The company's market cap stands at $14.3 million. Geovax Labs (NASDAQ:GOVX) shares moved upwards by
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersYS Biopharma Co (NASDAQ:YS) shares moved upwards by 72.0% to $1.34 during Friday's pre-market session. The company's market cap stands at $124.6 million. Longeveron Inc. - Subscription Right (N
Comera Life Sciences Announces Publication Of Study Reinforcing Caffeine's Viscosity Reducing Capabilities
Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodiesWOBURN, Mass., Aug.
The Chief Scientific Officer of Comera Life Sciences (CMRA.US) increased his holdings of common stock by 20,000 shares, worth approximately US$12,500
It was reported on August 16 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on August 15, Mahoney Robert Patrick, chief scientific officer of $Comera Life Sciences (CMRA.US) $, increased his holdings of common shares by 20,000 shares at an average price of 0.6252 US dollars per share on August 14, with a value of about 12,500 US dollars. Image source: SEC's official website What is a statement on changes in shareholding? The SEC requires listed company insiders to publicly disclose their securities transactions and shareholding information when the insider's shareholding changes
Comera Life Sciences Q2 EPS $(0.08) Up From $(1.14) YoY, Sales $315.06K Up From $146.73K YoY
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.08) per share. This is a 92.98 percent increase over losses of $(1.14) per share from the same period last year. The company report
No Data